Insulinoma differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Line 24: | Line 24: | ||
! rowspan="2" |Other Findings | ! rowspan="2" |Other Findings | ||
|- style="background: #4479BA; color: #FFFFFF; text-align: center;" | |- style="background: #4479BA; color: #FFFFFF; text-align: center;" | ||
!S.Glucose(mg/dL)/(mmol/L) | !S.Glucose<br>(mg/dL)/(mmol/L) | ||
!C Peptide (pmol/L) | !C Peptide (pmol/L) | ||
!S.Insulin (μU/mL)/(pmol/L) | !S.Insulin (μU/mL)/(pmol/L) | ||
!S.Proinsulin(pmol/L) | !S.Proinsulin<br>(pmol/L) | ||
!S. Beta hydroxybutyrate | !S. Beta hydroxybutyrate | ||
!Glucose increase after glucagon(mg/dL) | !Glucose increase after glucagon(mg/dL) |
Revision as of 20:49, 25 August 2017
Insulinoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Insulinoma differential diagnosis On the Web |
American Roentgen Ray Society Images of Insulinoma differential diagnosis |
Risk calculators and risk factors for Insulinoma differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]
Overview
Insulinoma must be differentiated from other diseases that cause features of hypoglycemia like palpitations, profuse sweating, dizziness, such as [differential dx1], [differential dx2], and [differential dx3].
OR
Insulinoma must be differentiated from the exogenous use of insulin, drugs causing hypoglycemia like sulfonylureas.
Differentiating insulinoma from other Diseases
- [Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].
- [Disease name] must be differentiated from [[differential dx1], [differential dx2], and [differential dx3].
- As [disease name] manifests in a variety of clinical forms, differentiation must be established in accordance with the particular subtype. [Subtype name 1] must be differentiated from other diseases that cause [clinical feature 1], such as [differential dx1] and [differential dx2]. In contrast, [subtype name 2] must be differentiated from other diseases that cause [clinical feature 2], such as [differential dx3] and [differential dx4].
Preferred Table for differentials for Hypoglycemia
Diseases | Laboratory Findings | History and Symptoms | Other Findings | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S.Glucose (mg/dL)/(mmol/L) |
C Peptide (pmol/L) | S.Insulin (μU/mL)/(pmol/L) | S.Proinsulin (pmol/L) |
S. Beta hydroxybutyrate | Glucose increase after glucagon(mg/dL) | Finding 1 | |||||||
Exogenous Insulin | ↓ | ↓ | ↑↑ | ||||||||||
Differential Diagnosis 2 | ' | ↑ | - | ||||||||||
Differential Diagnosis 3 | ↓ | ||||||||||||
Differential Diagnosis 4 | |||||||||||||
Differential Diagnosis 5 |
Use if the above table can not be made
Differential Diagnosis | Similar Features | Differentiating Features |
---|---|---|
Differential 1 |
|
|
Differential 2 |
|
|
Differential 3 |
|
|
Differential 4 |
|
|
Differential 5 |
|
|